University of Illinois College of Medicine at Chicago, University of Illinois at Chicago.
HEARD Support Group, University of Chicago, Chicago, Illinois.
Chest. 2011 Nov;140(5):1312-1318. doi: 10.1378/chest.11-0039. Epub 2011 May 5.
Epithelioid hemangioendothelioma (EHE) is a rare vascular neoplasm of endothelial origin with clinical behavior intermediate between hemangioma and angiosarcoma. The natural history of EHE is highly variable. This study uses an Internet registry to identify clinical patterns with prognostic significance in EHE.
Cases from the International Hemangioendothioma, Epithelioid Hemangioendothelioma, and Related Vascular Disorders (HEARD) Support Group were evaluated based on demographics, organ involvement, disease progression, presence or absence of pleural effusion, and treatment. Survival among various cohorts was compared using log-rank analysis of Kaplan-Meier plots.
Two hundred sixty-four patients were identified from April 2004 to November 2009. Fifty-eight cases were excluded because of inadequate information or wrong diagnosis. EHE was more common in female patients (61%). Male gender and age ≥ 55 years were associated with decreased survival. The most commonly affected organs were liver, lung, and bone. No specific organ or combination of organ involvement differentially affected survival, and survival was no different between patients with multiple vs single organ involvement. However, pattern B, defined as lesions without distinct borders (eg, pulmonary infiltrates, pleural effusion, ascites), hemoptysis, or involvement of more than two bones adversely affected survival in all cohorts.
A novel staging system with prognostic value for EHE is proposed. Pleural effusion or other signs of uncontained tumor growth, hemoptysis, and osseous involvement of more than two bones implied worse survival than did localized and discrete tumors, regardless of number of organs involved. A lay registry can provide useful insights into the clinical behavior of a rare cancer.
上皮样血管内皮细胞瘤(EHE)是一种罕见的血管肿瘤,起源于内皮细胞,其临床行为介于血管瘤和血管肉瘤之间。EHE 的自然病程变化较大。本研究使用互联网登记处确定 EHE 中具有预后意义的临床模式。
根据人口统计学、器官受累、疾病进展、是否存在胸腔积液以及治疗情况,对国际血管内皮细胞瘤、上皮样血管内皮细胞瘤和相关血管疾病(HEARD)支持组的病例进行评估。使用 Kaplan-Meier 图对数秩分析比较不同队列之间的生存情况。
2004 年 4 月至 2009 年 11 月期间共确定了 264 例患者。因信息不足或诊断错误,排除了 58 例病例。EHE 更常见于女性患者(61%)。男性和年龄≥55 岁与生存时间缩短相关。最常受累的器官是肝脏、肺和骨骼。没有特定的器官或器官组合会对生存产生不同的影响,而且在有多个或单个器官受累的患者之间,生存情况也没有差异。然而,模式 B,定义为边界不明确的病变(例如肺部浸润、胸腔积液、腹水)、咯血或累及超过两个骨骼,对所有队列的生存均有不利影响。
提出了一种具有预后价值的新型 EHE 分期系统。胸腔积液或其他提示肿瘤无控制生长的迹象、咯血和超过两个骨骼的骨累及比局限性和离散性肿瘤预后更差,而与受累器官数量无关。非专业的登记处可以为罕见癌症的临床行为提供有用的见解。